NCIt definition : An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor
of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth
factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively
binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis
and tumor cell proliferation.;
UNII : H3I42X8XX7;
CAS number : 1005780-62-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1005780-62-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;